Want to see COSM full AI Analyst Report?
COSM Stock Chart & Stats
$0.22
<$0.01(3.75%)
At close: 4:00 PM EDT
$0.22
<$0.01(3.75%)
Day’s Range― - ―
52-Week Range$0.16 - $1.32
Previous Close$0.2
Volume2.90M
Average Volume (3M)16.84M
Market Cap
$21.76M
Enterprise Value$25.04
Total Cash (Recent Filing)$1.84M
Total Debt (Recent Filing)$15.98M
Price to Earnings (P/E)―
Beta2.26
Next Earnings
Nov 17, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding100,633,770
10 Day Avg. Volume6,443,995
30 Day Avg. Volume16,844,547
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.23
P/FCF Ratio-1.77
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)$87.30M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained top-line expansion indicates improving product distribution and customer reach. If growth continues, greater scale could support operating leverage, although profitability must improve for this growth to create durable shareholder value.
Lower LeverageMeaningful debt reduction improves financial flexibility and lowers balance-sheet risk. The reduced leverage gives management more capacity to fund operations and pursue growth, though continued losses could eventually weaken the equity base.
High-Margin Product OpportunityOliv18 could materially improve the company’s product mix because its projected gross margin is far above the current corporate level. Successful U.S. commercialization would add a higher-quality revenue stream and support future margin expansion.
Bears Say
Thin Gross MarginsVery limited gross profitability leaves little cushion for distribution, selling, and administrative costs. Unless higher-margin products become a larger share of sales, revenue growth may continue without producing sustainable operating profits.
Persistent Cash BurnOngoing cash consumption reduces financial resilience and increases dependence on external funding or balance-sheet actions. This can constrain investment in growth and create recurring financing needs unless operations move toward positive cash generation.
Potential Equity DilutionThe new equity tools can improve access to financing and support employee incentives, but they also increase potential dilution. That risk is more material while the company reports substantial losses and relies on funding to offset cash burn.
Cosmos Holdings News
COSM FAQ
What was Cosmos Holdings Inc’s price range in the past 12 months?
Cosmos Holdings Inc lowest stock price was $0.16 and its highest was $1.32 in the past 12 months.
What is Cosmos Holdings Inc’s market cap?
Cosmos Holdings Inc’s market cap is $21.76M.
When is Cosmos Holdings Inc’s upcoming earnings report date?
Cosmos Holdings Inc’s upcoming earnings report date is Nov 17, 2026 which is in 80 days.
How were Cosmos Holdings Inc’s earnings last quarter?
Cosmos Holdings Inc released its earnings results on Aug 24, 2026. The company reported -$0.1 earnings per share for the quarter, the consensus estimate of -$0.1 by $0.
Is Cosmos Holdings Inc overvalued?
According to Wall Street analysts Cosmos Holdings Inc’s price is currently Overvalued.
Does Cosmos Holdings Inc pay dividends?
Cosmos Holdings Inc does not currently pay dividends.
What is Cosmos Holdings Inc’s EPS estimate?
Cosmos Holdings Inc’s EPS estimate is -0.05.
How many shares outstanding does Cosmos Holdings Inc have?
Cosmos Holdings Inc has 100,633,770 shares outstanding.
What happened to Cosmos Holdings Inc’s price movement after its last earnings report?
Cosmos Holdings Inc reported an EPS of -$0.1 in its last earnings report, expectations of -$0.1. Following the earnings report the stock price went down -6.787%.
Which hedge fund is a major shareholder of Cosmos Holdings Inc?
Currently, no hedge funds are holding shares in COSM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cosmos Holdings Inc
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Technical Analysis
Ownership Overview
17.36% Insiders
0.30% Mutual Funds
0.04% Other Institutional Investors
82.00% Public Companies and
Individual Investors